Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07334470 · ClinicalTrials.gov registry record · NA
Weight Bias Reducation Intervention With Nursing Students Using Simulation: The BRAVE Study
A NA study, sponsored by Villanova University.
- Not yet
- Registry status
- NA
- Development phase
- 368
- Enrollment target
NCT07334470: Clinical Trial NA study, sponsored by Villanova University.
NCT07334470 is a NA study that has not yet begun recruiting, run by Villanova University. The registered enrollment target is 368 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07334470, a NA study, has not yet begun recruiting, sponsored by Villanova University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 368 participants
- Enrollment target
Study Summary
This randomized controlled trial will be a curriculum-embedded weight sensitivity training program. There will be two groups. The control group will receive the standard obesity lecture (SOL) and the intervention group will receive the BRAVE Intervention (BRAVE: Building Respect and Acceptance through Valuing Everybody); a Weight Bias Reduction (WBR) intervention. Both groups will have two simulation encounters with standardized patients who are living with obesity and the outcome will be to improve weight bias and increase weight sensitivity over one year. Participants will include second- and fourth-year nursing students. Two cohorts of nursing students will be recruited over two years during orientation for their NUR courses (n = 368); a combined total of 420 students are typically enrolled in these courses. Study participants will be randomized by 8-person simulation groups (clusters) to either the BRAVE intervention or SOL control group. They will then participate in the two simulation-based experiences and weight bias reduction education or standard obesity lecture, respectively, with a debriefing segment and educational components. To compare the efficacy of BRAVE groups to SOL groups in validated questionnaires will assess changing attitudes, beliefs, and clinical communication behaviors when comparing baseline to 3 months post-intervention, and one year after the intervention.
Primary Outcome
Estimated Mean Change Score.The ATOP-HW is a 20-item Likert rating scale that focuses on perceptions and attitudes about people living with obesity. Higher scores reflect more positive attitudes toward persons with obesity.
Interventions
- BEHAVIORAL BRAVE
- BEHAVIORAL SOL: Standard Obesity Lecture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2026-01-12 |
| Est. Completion | 2028-05-20 |
| Phase | NA |
What is known before NCT07334470 opens enrollment
NCT07334470 is an interventional study that assigns participants to a tested intervention. The registered 368 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which BRAVE is the first listed.
NCT07334470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07334470 about?
NCT07334470 is a clinical study titled "Weight Bias Reducation Intervention With Nursing Students Using Simulation: The BRAVE Study". This randomized controlled trial will be a curriculum-embedded weight sensitivity training program. There will be two groups. The control group will receive the standard obesity lecture (SOL) and the intervention group will receive the BRAVE Intervention (BRAVE: Building Respect and Acceptance throu...
What is the current status of trial NCT07334470?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 368 participants. The study started on 2026-01-12. Estimated completion is 2028-05-20.
What interventions are being tested in trial NCT07334470?
The interventions under investigation include: BRAVE (BEHAVIORAL), SOL: Standard Obesity Lecture (BEHAVIORAL).
Who is sponsoring clinical trial NCT07334470?
This trial is sponsored by Villanova University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07334470's enrollment target sits among peer trials
368 283rd of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI